213 related articles for article (PubMed ID: 27803960)
1. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.
Kessel KA; Fischer H; Vogel MM; Oechsner M; Bier H; Meyer B; Combs SE
Strahlenther Onkol; 2017 Mar; 193(3):192-199. PubMed ID: 27803960
[TBL] [Abstract][Full Text] [Related]
2. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
3. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiotherapy of vestibular schwannoma : Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy.
Putz F; Müller J; Wimmer C; Goerig N; Knippen S; Iro H; Grundtner P; Eyüpoglu I; Rössler K; Semrau S; Fietkau R; Lettmaier S
Strahlenther Onkol; 2017 Mar; 193(3):200-212. PubMed ID: 27928625
[TBL] [Abstract][Full Text] [Related]
5. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
Söderlund Diaz L; Hallqvist A
J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
8. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
[TBL] [Abstract][Full Text] [Related]
10. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
11. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
12. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
14. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.
Meijer OW; Vandertop WP; Baayen JC; Slotman BJ
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1390-6. PubMed ID: 12873685
[TBL] [Abstract][Full Text] [Related]
15. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
[TBL] [Abstract][Full Text] [Related]
16. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose.
Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B
J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261
[TBL] [Abstract][Full Text] [Related]
17. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.
Chen Z; Takehana K; Mizowaki T; Uto M; Ogura K; Sakanaka K; Arakawa Y; Mineharu Y; Miyabe Y; Mukumoto N; Miyamoto S; Hiraoka M
Int J Clin Oncol; 2018 Aug; 23(4):608-614. PubMed ID: 29556918
[TBL] [Abstract][Full Text] [Related]
18. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
[TBL] [Abstract][Full Text] [Related]
19. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.
Fuss M; Debus J; Lohr F; Huber P; Rhein B; Engenhart-Cabillic R; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1381-7. PubMed ID: 11121637
[TBL] [Abstract][Full Text] [Related]
20. [Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma].
Hamm K; Herold HU; Surber G; Rosahl S
HNO; 2017 May; 65(5):434-442. PubMed ID: 28078405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
